| Date Filed | Type | Description |
| 05/12/2023 |
4
| Papapetropoulos Spyros (Director) has filed a Form 4 on Lipocine Inc.|
Txns:
| Granted 30,000 options to buy
@ $0.2656, valued at
$8k
|
|
| 11/28/2022 |
4
| Papapetropoulos Spyros (Director) has filed a Form 4 on Lipocine Inc.|
Txns:
| Bought 21,739 shares
@ $0.47, valued at
$10.2k
|
|
| 11/22/2022 |
4
| Papapetropoulos Spyros (Chief Medical Officer) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Sold 300 shares
@ $14, valued at
$4.2k
Exercised 300 options to buy
@ $1.89, valued at
$567 |
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2022 |
4
| Papapetropoulos Spyros (Chief Medical Officer) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Bought 4,000 shares
@ $3.3978, valued at
$13.6k
|
|
| 04/12/2022 |
4
| Papapetropoulos Spyros (Director) has filed a Form 4 on Lipocine Inc.|
Txns:
| Granted 10,000 options to buy
@ $1.16, valued at
$11.6k
|
|
| 04/12/2022 |
3
| Papapetropoulos Spyros (Director) has filed a Form 3 on Lipocine Inc. |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2022 |
3
| Papapetropoulos Spyridon (Chief Medical Officer) has filed a Form 3 on Vigil Neuroscience, Inc. |
| 11/24/2021 |
4
| Papapetropoulos Spyridon (Director) has filed a Form 4 on Adamas Pharmaceuticals Inc|
Txns:
| Unknown transaction of 20,975 shares
@ $0
Disposed/sold 20,000 options to buy
@ $4.35, valued at
$87k
Disposed/sold 10,000 options to buy
@ $5.21, valued at
$52.1k
|
|
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/24/2020 |
4
| Papapetropoulos Spyridon (Director) has filed a Form 4 on Adamas Pharmaceuticals Inc|
Txns:
| Granted 10,000 shares
@ $0
Granted 20,000 options to buy
@ $4.35, valued at
$87k
|
|
| 11/24/2020 |
3
| Papapetropoulos Spyridon (Director) has filed a Form 3 on Adamas Pharmaceuticals Inc |